LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer.
Authors: Di Mauro P; INSERM, UMR1033, F-69372 Lyon, France.; University of Lyon, F-69622 Villeurbanne, France., Croset M; INSERM, UMR1033, F-69372 Lyon, France.; University of Lyon, F-69622 Villeurbanne, France., Bouazza L; INSERM, UMR1033, F-69372 Lyon, France.; University of Lyon, F-69622 Villeurbanne, France., Clézardin P; INSERM, UMR1033, F-69372 Lyon, France.; University of Lyon, F-69622 Villeurbanne, France.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Reynaud C; INSERM, UMR1033, F-69372 Lyon, France.; University of Lyon, F-69622 Villeurbanne, France.
Source: Journal of bone oncology [J Bone Oncol] 2024 Jan 05; Vol. 44, pp. 100522. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101610292 Publication Model: eCollection Cited Medium: Print ISSN: 2212-1366 (Print) Linking ISSN: 22121366 NLM ISO Abbreviation: J Bone Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2212-1366
DOI:10.1016/j.jbo.2024.100522